
Cheneca Smith
Examiner (ID: 14432, Phone: (571)270-1651 , Office: P/2192 )
| Most Active Art Unit | 2192 |
| Art Unit(s) | 2192 |
| Total Applications | 489 |
| Issued Applications | 321 |
| Pending Applications | 38 |
| Abandoned Applications | 143 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18181366
[patent_doc_number] => 20230042095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => ANTIBODIES AGAINST LIF AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/808319
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17808319
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/808319 | ANTIBODIES AGAINST LIF AND USES THEREOF | Jun 22, 2022 | Abandoned |
Array
(
[id] => 20701473
[patent_doc_number] => 12624173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-12
[patent_title] => Biodegradable polymeric compositions, methods of preparation and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/829302
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 14653
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829302
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/829302 | Biodegradable polymeric compositions, methods of preparation and uses thereof | May 30, 2022 | Issued |
Array
(
[id] => 19381499
[patent_doc_number] => 20240271369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => POROUS MEDIA HAVING BIOCIDAL PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 18/559510
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559510
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559510 | POROUS MEDIA HAVING BIOCIDAL PROPERTIES | May 12, 2022 | Pending |
Array
(
[id] => 18311849
[patent_doc_number] => 20230115749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => PRESERVATIVE FOR IN VITRO DIAGNOSTIC REAGENT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/726486
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726486
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726486 | PRESERVATIVE FOR IN VITRO DIAGNOSTIC REAGENT AND USE THEREOF | Apr 20, 2022 | Abandoned |
Array
(
[id] => 19111109
[patent_doc_number] => 20240122859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/276864
[patent_app_country] => US
[patent_app_date] => 2022-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276864
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276864 | EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION | Feb 11, 2022 | Pending |
Array
(
[id] => 17837717
[patent_doc_number] => 20220275022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COMPOSITIONS, KITS AND METHODS USEFUL FOR ANALYZING ANTIBODY-CONTAINING SAMPLES
[patent_app_type] => utility
[patent_app_number] => 17/592260
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592260
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592260 | COMPOSITIONS, KITS AND METHODS USEFUL FOR ANALYZING ANTIBODY-CONTAINING SAMPLES | Feb 2, 2022 | Pending |
Array
(
[id] => 17412662
[patent_doc_number] => 20220047566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => LONG ACTING IN-SITU FORMING/GELLING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/404358
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17404358
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/404358 | LONG ACTING IN-SITU FORMING/GELLING COMPOSITIONS | Aug 16, 2021 | Pending |
Array
(
[id] => 18752494
[patent_doc_number] => 20230355750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => KINETICALLY ACTING ADJUVANT ENSEMBLE
[patent_app_type] => utility
[patent_app_number] => 18/040328
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040328
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040328 | KINETICALLY ACTING ADJUVANT ENSEMBLE | Aug 3, 2021 | Pending |
Array
(
[id] => 18536143
[patent_doc_number] => 20230241231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => CENTRAL NERVOUS SYSTEM DELIVERY OF PSILOCYBIN
[patent_app_type] => utility
[patent_app_number] => 18/004400
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004400
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004400 | CENTRAL NERVOUS SYSTEM DELIVERY OF PSILOCYBIN | Jul 29, 2021 | Pending |
Array
(
[id] => 18626735
[patent_doc_number] => 20230285541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHODS AND COMPOSITIONS FOR INCREASING IMMUNITY AGAINST CORONAVIRUSES
[patent_app_type] => utility
[patent_app_number] => 18/005900
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005900
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005900 | METHODS AND COMPOSITIONS FOR INCREASING IMMUNITY AGAINST CORONAVIRUSES | Jul 19, 2021 | Abandoned |
Array
(
[id] => 18673146
[patent_doc_number] => 20230310631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => THERAPEUTIC USE OF GLUCAGON DERIVATIVE OR CONJUGATE THEREOF FOR LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/016165
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016165
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016165 | THERAPEUTIC USE OF GLUCAGON DERIVATIVE OR CONJUGATE THEREOF FOR LIVER DISEASE | Jul 14, 2021 | Pending |
Array
(
[id] => 18612414
[patent_doc_number] => 20230279146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => VISCOSITY REDUCING EXCIPIENTS AND COMBINATIONS THEREOF FOR HIGHLY CONCENTRATED PROTEIN FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/015378
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015378
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015378 | VISCOSITY REDUCING EXCIPIENTS AND COMBINATIONS THEREOF FOR HIGHLY CONCENTRATED PROTEIN FORMULATIONS | Jul 11, 2021 | Pending |
Array
(
[id] => 18626779
[patent_doc_number] => 20230285586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 18/017179
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017179
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017179 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES | Jul 8, 2021 | Pending |
Array
(
[id] => 18628254
[patent_doc_number] => 20230287108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => MUSCLE-TARGETING COMPLEXES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/017180
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017180
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017180 | MUSCLE-TARGETING COMPLEXES AND USES THEREOF | Jul 8, 2021 | Pending |
Array
(
[id] => 18738054
[patent_doc_number] => 20230346966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY
[patent_app_type] => utility
[patent_app_number] => 18/017182
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017182
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017182 | MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY | Jul 8, 2021 | Abandoned |
Array
(
[id] => 18658993
[patent_doc_number] => 20230304992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => GROWTH AND SITE-SPECIFIC ORGANIZATION OF MICRO-SCALE BIMOLECULAR DEVICES ON LIVING CELLS
[patent_app_type] => utility
[patent_app_number] => 18/003462
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003462
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003462 | GROWTH AND SITE-SPECIFIC ORGANIZATION OF MICRO-SCALE BIMOLECULAR DEVICES ON LIVING CELLS | Jun 28, 2021 | Pending |
Array
(
[id] => 18647898
[patent_doc_number] => 20230293677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => USE OF A DERIVATIVE OF SYNTHETIC PHTHALHYDRAZIDE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/016650
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016650
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016650 | USE OF A DERIVATIVE OF SYNTHETIC PHTHALHYDRAZIDE DERIVATIVES | Jun 28, 2021 | Abandoned |
Array
(
[id] => 18567107
[patent_doc_number] => 20230257436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => Cell Lines Secreting Alpha-Synuclein Targeting Antibodies, Progranulin and Prosaposin and a Complex of Both, and GDNF
[patent_app_type] => utility
[patent_app_number] => 18/011647
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -115
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011647
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011647 | Cell Lines Secreting Alpha-Synuclein Targeting Antibodies, Progranulin and Prosaposin and a Complex of Both, and GDNF | Jun 20, 2021 | Abandoned |
Array
(
[id] => 18626782
[patent_doc_number] => 20230285590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => POLYMER-CARGO-COMPLEXES COMPRISING CROSS-LINKED COPOLYMERS AND CARGO MOLECULES
[patent_app_type] => utility
[patent_app_number] => 18/011716
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011716
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011716 | POLYMER-CARGO-COMPLEXES COMPRISING CROSS-LINKED COPOLYMERS AND CARGO MOLECULES | Jun 17, 2021 | Pending |
Array
(
[id] => 18753984
[patent_doc_number] => 20230357341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => FUSION PROTEIN CONTAINING ERYTHROPOIETIN POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 18/009601
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009601
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009601 | FUSION PROTEIN CONTAINING ERYTHROPOIETIN POLYPEPTIDE | Jun 8, 2021 | Pending |